ALLO – allogene therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ALLO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/10

04:54 pm

allo

Form 4 Allogene Therapeutics, For: Dec 09 Filed by: MESSEMER DEBORAH M.

Low Report

Form 4 Allogene Therapeutics, For: Dec 09 Filed by: MESSEMER DEBORAH M.

Report

12/9

04:06 pm

allo

Form 4 Allogene Therapeutics, For: Dec 05 Filed by: Humer Franz B

Medium Report

Form 4 Allogene Therapeutics, For: Dec 05 Filed by: Humer Franz B

Report

12/9

04:03 pm

allo

Form 144 Allogene Therapeutics, Filed by: MESSEMER DEBORAH M.

Medium Report

Form 144 Allogene Therapeutics, Filed by: MESSEMER DEBORAH M.

Report

12/4

02:16 pm

allo

Form 144/A Allogene Therapeutics, Filed by: Humer Franz B

Low Report

Form 144/A Allogene Therapeutics, Filed by: Humer Franz B

Report

12/2

02:12 pm

allo

Form 144 Allogene Therapeutics, Filed by: Humer Franz B

Low Report

Form 144 Allogene Therapeutics, Filed by: Humer Franz B

Report

11/13

04:30 pm

allo

Form 8-K Allogene Therapeutics, For: Nov 11

Medium Report

Form 8-K Allogene Therapeutics, For: Nov 11

Report

11/12

01:27 pm

allo

Form SC 13G/A Allogene Therapeutics, Filed by: VANGUARD GROUP INC

Low Report

Form SC 13G/A Allogene Therapeutics, Filed by: VANGUARD GROUP INC

Report

11/8

02:20 pm

allo

Form SC 13G/A Allogene Therapeutics, Filed by: BlackRock, Inc.

Low Report

Form SC 13G/A Allogene Therapeutics, Filed by: BlackRock, Inc.

Report

11/7

04:15 pm

allo

Form 10-Q Allogene Therapeutics, For: Sep 30

Medium Report

Form 10-Q Allogene Therapeutics, For: Sep 30

Report

11/7

04:06 pm

allo

Form 8-K Allogene Therapeutics, For: Nov 07

Medium Report

Form 8-K Allogene Therapeutics, For: Nov 07

Report

11/4

10:57 am

allo

Form SC 13G Allogene Therapeutics, Filed by: VANGUARD GROUP INC

Low Report

Form SC 13G Allogene Therapeutics, Filed by: VANGUARD GROUP INC

Report

10/23

04:22 pm

allo

Form 4 Allogene Therapeutics, For: Oct 21 Filed by: Parker Geoffrey M.

Medium Report

Form 4 Allogene Therapeutics, For: Oct 21 Filed by: Parker Geoffrey M.

Report

10/22

03:25 pm

allo

Form SC 13G/A Allogene Therapeutics, Filed by: BlackRock, Inc.

Low Report

Form SC 13G/A Allogene Therapeutics, Filed by: BlackRock, Inc.

Report

10/21

04:06 pm

allo

Form 144 Allogene Therapeutics, Filed by: Parker Geoffrey M.

Neutral Report

Form 144 Allogene Therapeutics, Filed by: Parker Geoffrey M.

Report

10/7

04:28 pm

allo

Form 8-K Allogene Therapeutics, For: Oct 03

Medium Report

Form 8-K Allogene Therapeutics, For: Oct 03

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.